(Q53305093)

13 May 2018

title

Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. (English)

1 reference

13 May 2018

1 reference

K J Reinikainen

1 reference

13 May 2018

L Paljärvi

1 reference

13 May 2018

T Halonen

1 reference

13 May 2018

O Malminen

1 reference

13 May 2018

V M Kosma

1 reference

13 May 2018

M Laakso

1 reference

13 May 2018

P J Riekkinen

1 reference

13 May 2018

publication date

1 May 1988

1 reference

13 May 2018

published in

Neurobiology of Aging

1 reference

13 May 2018

volume

1 reference

13 May 2018

issue

1 reference

13 May 2018

page(s)

245-252

1 reference

13 May 2018

Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Neuropeptides in neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Monoamine metabolism in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

A subcortico-cortical cholinergic system is affected in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

The effect of age on the activity and molecular properties of human brain monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Transmitter deficits in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Parkinson's disease in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Alzheimer's disease: neuropathological correlates of cognitive and motor disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Cortical neuronal counts in normal elderly controls and demented patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

The cholinergic hypothesis--ten years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Dementia and Parkinson's disease--pathological and neurochemical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Clinical and etiological aspects of senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Dementia of the Alzheimer Type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Neocortical cell counts in normal human adult aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Some morphometric aspects of the brain in senile dementia of the alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2888%2980061-7

7 January 2021

10.1016/S0197-4580(88)80061-7

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018